TwistDx
Abbott's TwistDx Subsidiary to Consolidate Operations in San Diego
Abbott confirmed that the move is a consequence of TwistDx evaluating its operations and strategic direction to align operations and commercial needs.
The portable device runs an isothermal amplification assay to detect genetic material from strains of tuberculosis in resource limited areas.
Dubbed "Sherlock," the new technology has demonstrated potential in detecting viruses and bacteria as well as human SNPs and mutations in cell-free DNA.
The adaptable technology uses flow-through microfluidic chips and can detect three pathogens simultaneously with virtually unlimited potential array sizes.
The system uses off-the-shelf laboratory components and currently runs an Ebola assay based on isothermal amplification chemistry from Alere subsidiary TwistDx.